Peregrine Pharmaceuticals has initiated patient screening and dosing in a Phase II trial designed to evaluate the safety and efficacy of bavituximab in combination with chemotherapy in patients with non-small cell lung cancer....

Located @ http://www.lungblog.com/2008/07/02/peregr
ine-initiates-dosing-in-phase-ii-lung-cancer-trial/.